VBI Vaccines (VBIV) Momentum Indicators
Post# of 84
Posted On: 04/06/2015 11:13:34 PM
Shares of VBI Vaccines Inc. (VBIV) soared more than 20% in after-hours trading on Monday, following the announcement that Sanofi Pasteur has chosen VBIV's LPV(TM) (Lipid Particle Vaccine) formulation technology and expertise to reformulate a Sanofi Pasteur vaccine candidate to provide improved stability.
As part of the collaboration agreement, Sanofi Pasteur has the option to acquire certain worldwide rights to use VBIV's LPV(TM) technology in its vaccines. The vaccine candidate and the terms of the agreement were not disclosed.
VBIV is a biopharmaceutical company developing novel technologies that seek to expand vaccine protection in large underserved markets.
More about VBI Vaccines Inc. (VBIV) at www.vbivaccines.com
**
After the closing bell on Monday, Clovis Oncology, Inc. (CLVS) said that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for its investigational agent rucaparib as monotherapy treatment of advanced ovarian cancer in patients who have received at least two lines of prior platinum-containing therapy.
This means that the FDA will expedite the development and review of CLVS' rucaparib, an oral, potent inhibitor of PARP1 and PARP2 being developed for the treatment of platinum-sensitive ovarian cancer in patients with BRCA mutations (genes that are linked to breast and ovarian cancers) and other DNA repair deficiencies.
The price of CLVS stock surged more than 7% in extended-hours trading.
CLVS is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets.
More about Clovis Oncology, Inc. (CLVS) at www.clovisoncology.com
**
Institutional Shareholder Services, a leading independent proxy advisory firm, has recommended that Wynn Resorts, Limited (WYNN) stockholders vote on the WHITE proxy card at the Company's Annual Meeting of Stockholders to be held on April 24, 2015. It also recommended WYNN stockholders do not vote for Elaine Wynn on the gold card.
WYNN's Board of Directors has recommended that stockholders vote on the WHITE proxy card FOR the election of two Class I directors, Mr. John J. Hagenbuch and Mr. J. Edward Virtue, to serve until the 2018 Annual Meeting of Stockholders. The Board of Directors strongly believes that the Company's nominees are the most qualified candidates to serve on the Board.
Meanwhile, Elaine Wynn, co-founder, Board member and third-largest stockholder of WYNN, said that she believes that her role as co-founder of the Company is an asset to the Board and her experience is unmatched by other Board candidates. She has filed a proxy statement with a GOLD proxy card with the SEC in order to solicit votes for her re-nomination to the Board.
According to Elaine Wynn, the question WYNN stockholders should be asking is a simple one: which of the candidates is best positioned to protect and grow stockholder value over the long-term?
In the middle of this situation, where at the end shareholders will have the final word, WYNN stock closed at $130.72, up $1.32 (or +1.02%) on Monday's trading session.
WYNN, together with its subsidiaries, develops, owns, and operates destination casino resorts. It operates in two segments, Macau Operations and Las Vegas Operations
More about Wynn Resorts, Limited (WYNN) at www.wynnresorts.com
**
Crown Equity Holdings Inc. (CRWE) is currently developing its CRWE Network ( www.CRWE-PR.com ), a growing network of community targeted sites.
It has recently included Carson City, NV ( www.carsoncity.crwe-pr.com ) into the CRWE Network.
Carson City is the capital of the state of Nevada. It is located about 30 miles south of Reno. Carson City boasts an array of unique restaurants, challenging golf courses, historical attractions, museums, gaming opportunities and a plethora of year-round, outdoor experiences.
Carson City had an estimated population in 2014 (U.S. Census Bureau) of 54,522, and represents an important marketplace for the CRWE Network, which business model is based on selling advertising to businesses targeting both locally and nationally
The CRWE Network has reached the 1487th community website in the U.S. and includes coverage in the states of California, Mississippi, Michigan, Florida, Nevada and New York, as well as across 10 provinces in Canada.
CRWE provides marketing solutions that boost customer awareness and merchant visibility on the Internet.
More about Crown Equity Holdings Inc. (CRWE) at www.crownequityholdings.com
**
Disclaimer: CRWE-PR Finance is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read Full Disclaimer at CRWE-PR Finance www.finance.crwe-pr.com/disclaimer
As part of the collaboration agreement, Sanofi Pasteur has the option to acquire certain worldwide rights to use VBIV's LPV(TM) technology in its vaccines. The vaccine candidate and the terms of the agreement were not disclosed.
VBIV is a biopharmaceutical company developing novel technologies that seek to expand vaccine protection in large underserved markets.
More about VBI Vaccines Inc. (VBIV) at www.vbivaccines.com
**
After the closing bell on Monday, Clovis Oncology, Inc. (CLVS) said that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for its investigational agent rucaparib as monotherapy treatment of advanced ovarian cancer in patients who have received at least two lines of prior platinum-containing therapy.
This means that the FDA will expedite the development and review of CLVS' rucaparib, an oral, potent inhibitor of PARP1 and PARP2 being developed for the treatment of platinum-sensitive ovarian cancer in patients with BRCA mutations (genes that are linked to breast and ovarian cancers) and other DNA repair deficiencies.
The price of CLVS stock surged more than 7% in extended-hours trading.
CLVS is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets.
More about Clovis Oncology, Inc. (CLVS) at www.clovisoncology.com
**
Institutional Shareholder Services, a leading independent proxy advisory firm, has recommended that Wynn Resorts, Limited (WYNN) stockholders vote on the WHITE proxy card at the Company's Annual Meeting of Stockholders to be held on April 24, 2015. It also recommended WYNN stockholders do not vote for Elaine Wynn on the gold card.
WYNN's Board of Directors has recommended that stockholders vote on the WHITE proxy card FOR the election of two Class I directors, Mr. John J. Hagenbuch and Mr. J. Edward Virtue, to serve until the 2018 Annual Meeting of Stockholders. The Board of Directors strongly believes that the Company's nominees are the most qualified candidates to serve on the Board.
Meanwhile, Elaine Wynn, co-founder, Board member and third-largest stockholder of WYNN, said that she believes that her role as co-founder of the Company is an asset to the Board and her experience is unmatched by other Board candidates. She has filed a proxy statement with a GOLD proxy card with the SEC in order to solicit votes for her re-nomination to the Board.
According to Elaine Wynn, the question WYNN stockholders should be asking is a simple one: which of the candidates is best positioned to protect and grow stockholder value over the long-term?
In the middle of this situation, where at the end shareholders will have the final word, WYNN stock closed at $130.72, up $1.32 (or +1.02%) on Monday's trading session.
WYNN, together with its subsidiaries, develops, owns, and operates destination casino resorts. It operates in two segments, Macau Operations and Las Vegas Operations
More about Wynn Resorts, Limited (WYNN) at www.wynnresorts.com
**
Crown Equity Holdings Inc. (CRWE) is currently developing its CRWE Network ( www.CRWE-PR.com ), a growing network of community targeted sites.
It has recently included Carson City, NV ( www.carsoncity.crwe-pr.com ) into the CRWE Network.
Carson City is the capital of the state of Nevada. It is located about 30 miles south of Reno. Carson City boasts an array of unique restaurants, challenging golf courses, historical attractions, museums, gaming opportunities and a plethora of year-round, outdoor experiences.
Carson City had an estimated population in 2014 (U.S. Census Bureau) of 54,522, and represents an important marketplace for the CRWE Network, which business model is based on selling advertising to businesses targeting both locally and nationally
The CRWE Network has reached the 1487th community website in the U.S. and includes coverage in the states of California, Mississippi, Michigan, Florida, Nevada and New York, as well as across 10 provinces in Canada.
CRWE provides marketing solutions that boost customer awareness and merchant visibility on the Internet.
More about Crown Equity Holdings Inc. (CRWE) at www.crownequityholdings.com
**
Disclaimer: CRWE-PR Finance is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read Full Disclaimer at CRWE-PR Finance www.finance.crwe-pr.com/disclaimer
(0)
(0)VBI Vaccines Inc. (VBIVQ) Stock Research Links
Scroll down for more posts ▼